POL.it POL.it banner POL.it banner POL.it banner POL.it banner logo feedback POL.it banner
POL.it banner POL.it banner POL.it banner POL.it banner POL.it banner POL.it banner POL.it banner
POL.it banner POL.it banner POL.it banner POL.it banner POL.it banner POL.it banner POL.it banner

spazio bianco


Fabio Ranzini 1, Emilio Sacchetti2

1 I Unità Operativa Clinicizzata di Psichiatria, Azienda Spedali Civili, Brescia.
2 II Cattedra di Psichiatria- Università degli Studi di Brescia






Bentkover JD. Feighner JP. (1995) Cost analysis of paroxetine versus imipramine in major depression. Pharmacoeconomics 8:223-232.

Callahan CM., Kesterson JG., Tierney WM. (1997) Association of symptoms of depression with diagnostic test charges among older adults. Ann Intern Med, 126: 426-432.

Crott R., Gilis P. (1998) Economic comparisons of the pharmacotherapy of depression – An overview Acta Psychiatr Scand. 97: 241-252.

D'Mello DA., Finkbeiner DS., Kocher KN. (1995) The cost of antidepressant overdose. Gen Hosp Psychiatry, 17: 454-455.

Forder J., Kavanagh S., Fenyo A. (1996) A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care. J of Affective Disorders. 38: 97-111.

Greenberg PE., Stiglin LE., Finkelstein SN., Berndt ER. (1993) The economic burden of depression in 1990. J Clin Psychiatry. 54: 405-18.

Hatziandreu E.J. et al. PharmacoEconomics. 1994; 5:249-264.

Jonsson B., Bebbington P. In: Jonsson B., Bebbington P(eds). Health Economics of Depression. Perspectives in Psychiatry. Chichester: John Wiley & Sons LTD 1993; 4:35-48.

Jonsson B., Bebbington PE. (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry, 164: 665-673.

Kaplan H.I., Sadock B.J. Comprehensive Textbook of Psychiatry /V. Baltimore, Maryland: Ed. Williams & Wilkins. 1989:859-867.

Kaplan H.I.;Sadock B.J.; Creb J.A. IN : Kaplan & Sadock’s Synopsis of Psychiatry. Baltimore: Williams & Wilkins. 1994 ; 31 : 803-823.

Kessler RC., McGonagle KA., Zhao S., et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 51(1):8-19

Kind P., Sorensen J. (1993) The costs of depression. Int Clin Psychopharmacol; 7:191-195.

Lapierre Y., Bentkover J., Schainbaum S., Manners S. (1995) Direct cost of depression: Analysis of treatment costs of paroxetine versus impramine in Canada. Can J Psychiatry, 40: 370-377.

Lasser R., Siegel E., Dukoff R., Sunderland T. (1998). Diagnosis and treatment of geriatric depression. CNS Drugs. 9:17-30.

Lepine JP., Gastpar M., Mendlewicz J., Tylee A. (1997). Depression in the community - The first Pan-European study DEPRES (Depression Research In European Society). Int. Clin. Psychopharmacol. 12:19-29.

Melton ST., Kirkwood CK., Farrar TW., Brink DD., Carroll NV. (1997). Economic evaluation of paroxetine and imipramine in depressed outpatients. Psychopharmacol. Bull., 33: 93-100.

Mendlewicz J. (1989) The social burden of depressive disorders. Neuropsychobiology. 22: 178-180.

Montgomery SA. (1992) Suicide and antidepressants. Drugs 43 Suppl 2:24-31.

Montgomery SA., Brown RE., Clark M. (1996) Economic analysis of treating depression with nefazodone v imipramine. Br. J. Psychiatry, 168: 768-771.

Nuijten MJC., Hardens M., Souetre E. (1995) A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression. PharmacoEconomics, 8: 159-168.

Report of the National Advisory Menthal Health Council. Am J Psychiatry 1993; 150:10.

Rutz W., Carlsson P., Von Knorring L., Walinder J. (1992) Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiatr Scand, 85: 457-464.

Sacchetti E. Bollettino di informazioni medico statistiche. 1994; 53:4-34.

Sclar DA., Robison LM., Skaer TL., Legg RF., Nemec NL., Galin RS., Hughes TE., Buesching DP. (1994) Antidepressant pharmacotherapy: Economic outcomes in a health maintenance organization. Clin Ther, 16: 715-730.

Simon G., Ormel J., VonKorff M., Barlow W. (1995) Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry, 52: 352-357.

Souetre E., Lozet H., Martin P., Lecanu JP., Gauthier JM., Beuzen JN., Ravily V. (1993) Impact of fluoxetine on work loss in depression. Therapie, 48: 81-88.

Stoudemire A., Frank R., Hedemark N., et al. (1986) The economic burden of depression. Gen Hosp Psychiatry, 8: 387-394.

Sturm R., Wells KB. (1995) How can care for depression become more cost-effective? JAMA, 273: 51-58.

Unutzer J., Patrick DL., Simon G., Grembowski D., Walker E., Rutter C., Katon W. (1997) Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: A 4-year prospective study. JAMA, 277: 1618-23.

Verbosky LA., Franco KN., Zrull JP. (1993) The relationship between depression and length of stay in the general hospital patient. J Clin Psychiatry, 54:179-181.

spazio bianco


spazio bianco

Priory lodge LTD

Click Here!